Therapy News and Research

RSS

Cell Therapeutics announces launch of PIXUVRI in the UK for treatment of aggressive B-cell NHL

Cell Therapeutics, Inc. today announced the launch of PIXUVRI (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (aggressive B-cell NHL), at the 54th annual scientific meeting of the British Society for Haematology.

29 Apr 2014

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing and commercializing transformative therapeutics using its proprietary ARCUSTM technology, today announced positive results from a Phase 2b clinical trial of CVT-301, an inhaled formulation of levodopa (L-dopa).

29 Apr 2014

Study: Mutations could have major impact on treatment of human blood diseases

A study published today in Nature Genetics has revealed mutations that could have a major impact on the future diagnosis and treatment of many human diseases.

29 Apr 2014

Research to understand how low blood sugars cause irregular heartbeats in diabetes

Dangerous overnight blood sugar levels often go undetected and cause prolonged periods of heart rhythm disturbances in older patients with Type 2 diabetes and associated heart problems, new research reveals.

29 Apr 2014

High rate of chronic pain found after general surgery

More than 2 years after undergoing an operation, almost 15% of general surgery patients suffer from chronic postsurgical pain, say researchers.

28 Apr 2014

Adherence optimises success of primary care hypertension programme

The value of a structured hypertension-treatment programme in primary care increases with increasing adherence to the programme, say researchers.

28 Apr 2014

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").

28 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

Researchers develop art-based program to help prevent heart disease

For patients with end stage heart disease who need a heart transplant, the experience of an extended hospitalization while waiting for a life-saving organ and then undergoing life-saving surgery can be an emotional and stressful journey.

28 Apr 2014

Women who had chemotherapy less likely to be employed 4 years later

Nearly one-third of breast cancer survivors who were working when they began treatment were unemployed four years later. Women who received chemotherapy were most affected, according to a new study from the University of Michigan Comprehensive Cancer Center.

28 Apr 2014

Life stressors may activate neurological disorders

When mothers are exposed to trauma, illness, alcohol or other drug abuse, these stressors may activate a single molecular trigger in brain cells that can go awry and activate conditions such as schizophrenia, post-traumatic stress disorder and some forms of autism.

26 Apr 2014

Highlights from April 2014 issue of Mayo Clinic Health Letter

Here are highlights from the April issue of Mayo Clinic Health Letter.

26 Apr 2014

Finnish researchers discover gene mutation in ameloblastoma

A Finnish team of researchers was the first in the world to discover a gene mutation in ameloblastoma, which is a tumour of the jaw.

26 Apr 2014

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has approved VOKANAMET® (a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet) in the European Union, for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control.

26 Apr 2014

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

A national response to the epidemic of prescription opioid overdose deaths was outlined yesterday in the New England Journal of Medicine by leaders of agencies in the U.S. Department of Health and Human Services.

26 Apr 2014

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.

26 Apr 2014

Gore announces nominees for 2014-2015 Pioneers in Performance Awards for Latin America

W. L. Gore & Associates today announced the nominees and opening of voting for the 2014-2015 Pioneers in Performance Awards for Latin America. The announcement came at the Congreso Internacional Cirugia Endovascular 2014 conference in São Paulo.

26 Apr 2014

Stem cell production becomes much easier with polymer-based 3D culture system

Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.

26 Apr 2014

Methadone safety: New clinical practice guideline from American Pain Society

Improved physician education and patient counseling about methadone safety and ECG monitoring to identify patients at high risk for cardiac problems will lead to safer use of the medication, according to the American Pain Society's Clinical Practice Guideline on Methadone Safety, published this week in The Journal of Pain.

26 Apr 2014

Research roundup: Structural concerns in ACOs; public's view of mandated contraception coverage

The Medicare Accountable Care Organization (ACO) programs reward participating health care provider groups that achieve slower spending growth and high quality of care.

26 Apr 2014

Therapy News and Research

Cell Therapeutics announces launch of PIXUVRI in the UK for treatment of aggressive B-cell NHL

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Study: Mutations could have major impact on treatment of human blood diseases

Research to understand how low blood sugars cause irregular heartbeats in diabetes

High rate of chronic pain found after general surgery

Adherence optimises success of primary care hypertension programme

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Voluntis closes €20.75 million ($29 million) Series D financing round

Researchers develop art-based program to help prevent heart disease

Women who had chemotherapy less likely to be employed 4 years later

Life stressors may activate neurological disorders

Highlights from April 2014 issue of Mayo Clinic Health Letter

Finnish researchers discover gene mutation in ameloblastoma

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

Gore announces nominees for 2014-2015 Pioneers in Performance Awards for Latin America

Stem cell production becomes much easier with polymer-based 3D culture system

Methadone safety: New clinical practice guideline from American Pain Society

Research roundup: Structural concerns in ACOs; public's view of mandated contraception coverage

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News